Abstract

Obesity has increasingly become a major medical and public health burden in both developed and developing countries. Numerous hormones are involved in controlling appetite and food intake via the neuro-humoral gut-brain axis and several peptides that are synthesized and secreted from the gut have been recently investigated in order to determine their effects on food intake and satiety. Ghrelin is an appetite-stimulating peptide that rises in the fasted state causing increases in food intake. Obestatin is a newly discovered hormone encoded by the same gene as ghrelin, and its putative role in the regulation of appetite and metabolism is unclear. A number of studies using animal models have shown that obestatin opposes the effects of ghrelin on food intake whilst others found that obestatin has little if any affect on gastrointestinal motility, or on food intake. There are also controversies to the receptor mediating obestatin effects with the previously orphan G protein coupled receptor GPR39 suggested to be the main candidate. Investigating the molecular mechanism underlying obestatin and other gut hormones involved in appetite regulation may prove to be useful in finding new strategies to treat obesity. Keywords: Ghrelin, obestatin

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.